IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in IGC Pharma, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +7 vs. Q4 2025
- Shares held
- 4.33M
- +650.5K (+17.7%) vs. Q4 2025
- Total value
- $1.14M
- +$103.2K (+10.0%) vs. Q4 2025
- New holders
- 11
- 6 more added
- Sold out
- 4
- 5 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Triumph Capital Management | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Napier Financial, LLC | 58 | $15 | 0.00% | +58 | New |
| DHJJ Financial Advisors, Ltd. | 80 | $22 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 100 | $26 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 101 | $27 | 0.00% | +1+1.0% | Added |
| Caitlin John, LLC | 200 | $53 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,000 | $263 | 0.00% | +1,000 | New |
| Geneos Wealth Management Inc. | 3,000 | $780 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,762 | $989 | 0.00% | −3,425−47.7% | Reduced |
| Trask Adam Roland | 5,000 | $1.31K | 0.00% | +5,000 | New |
| UBS Group AG | 8,097 | $2.13K | 0.00% | −11,772−59.2% | Reduced |
| HighTower Advisors, LLC | 10,000 | $2.63K | 0.00% | +10,000 | New |
| Schneider Downs Wealth Management Advisors, LP | 10,000 | $2.63K | 0.00% | +10,000 | New |
| Wealthcare Advisory Partners LLC | 10,000 | $2.63K | 0.00% | +10,000 | New |
| Vanguard Global Advisers, LLC | 14,944 | $3.93K | 0.00% | +14,944 | New |
| T3 Companies, LLC | 20,000 | $5.26K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 21,049 | $5.54K | 0.00% | +6,657+46.3% | Added |
| Virtu Financial LLC | 23,233 | $6.00K | 0.00% | +23,233 | New |
| Commonwealth Equity Services, LLC | 33,848 | $8.90K | 0.00% | +500+1.5% | Added |
| Morgan Stanley | 35,118 | $9.24K | 0.00% | +17,411+98.3% | Added |
| Truist Financial Corp | 36,667 | $9.64K | 0.00% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 43,400 | $11.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 50,648 | $13.3K | 0.00% | +22,324+78.8% | Added |
| Dearborn Partners LLC | 59,401 | $15.6K | 0.00% | −25,000−29.6% | Reduced |
| Goldman Sachs Group Inc | 65,541 | $17.2K | 0.00% | 00.0% | Unchanged |
| Lawood & Co | 75,000 | $19.7K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 113,407 | $29.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 122,595 | $32.2K | 0.00% | −32,364−20.9% | Reduced |
| State Street Corp | 200,799 | $52.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 415,888 | $109.4K | 0.00% | +415,888 | New |
| Renaissance Technologies LLC | 483,975 | $127.3K | 0.00% | −435,666−47.4% | Reduced |
| BlackRock, Inc. | 703,798 | $185.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 718,436 | $188.9K | 0.00% | +718,436 | New |
| Geode Capital Management, LLC | 1,043,384 | $274.4K | 0.00% | +182,907+21.3% | Added |
| Johnson Financial Group, Inc. | 1 | – | – | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −277,594−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,808−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |